DOI QR코드

DOI QR Code

Oncologic manifestations of neurofibromatosis type 1 in Korea

  • Kim, Eui-Tae (Department of Surgery, Dankook University College of Medicine) ;
  • NamGung, Hwan (Department of Surgery, Dankook University College of Medicine) ;
  • Shin, Hyun-Deok (Department of Internal Medicine, Dankook University College of Medicine) ;
  • Lee, Soon-Il (Department of Internal Medicine, Dankook University College of Medicine) ;
  • Kwon, Jee-Eun (Department of Pathology, Dankook University College of Medicine) ;
  • Chang, Myung-Chul (Department of Surgery, Dankook University College of Medicine) ;
  • Park, Dong-Guk (Department of Surgery, Dankook University College of Medicine)
  • Published : 2012.04.01

Abstract

Purpose: The aim of this study was to investigate the incidence and spectrum of malignant tumors in Korean neurofibromatosis type 1 (NF1) patients. Methods: We retrospectively reviewed 125 patients who were diagnosed with NF1 at a single institution from 1995 to 2010. The incidence, location, histologic type, and radiologic findings of malignant tumors as well as development of multiple primary tumors were analyzed. Results: Eighteen malignant tumors occurred in 16 patients (12.8%) among 125 Korean NF1 patients; 9 carcinomas, 8 sarcomas and 1 central nervous system (CNS) tumor. Five tumors were of nervous system origin and 13 were non-nervous system tumors. The locations of the tumors were as follow: 1 CNS, 2 lung, 3 breast, 3 stomach, 3 small bowel, 1 colon, 1 liver, 1 uterus, 1 neck, and 2 in extremities. Three malignant peripheral nerve sheath tumors (MPNSTs) occurred at the neck and extremity, and one in the liver. All three gastrointestinal stromal tumors (GISTs) had multiple tumors in the jejunum, and one MPNST and one pheochromocytoma were accompanied in two GISTs. Multiple primary tumors, benign or malignant were reported in 4 patients (25.0%), synchronously or metachronously. Conclusion: Korean NF1 patients had a high risk of developing malignant tumors. The common malignant tumors in Koreans such as breast, lung and stomach cancers developed frequently in addition to the NF1-related tumors such as MPNST or GIST.

Keywords

References

  1. Zoller ME, Rembeck B, Oden A, Samuelsson M, Angervall L. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 1997;79:2125-2131. https://doi.org/10.1002/(SICI)1097-0142(19970601)79:11<2125::AID-CNCR9>3.0.CO;2-N
  2. Korf BR. Malignancy in neurofibromatosis type 1. Oncologist 2000;5:477-485. https://doi.org/10.1634/theoncologist.5-6-477
  3. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988;45:575-578. https://doi.org/10.1001/archneur.1988.00520290115023
  4. Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med 2010;12:1-11.
  5. Brems H, Beert E, de Ravel T, Legius E. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 2009;10:508-515. https://doi.org/10.1016/S1470-2045(09)70033-6
  6. Miettinen M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol 2006;30:90-96. https://doi.org/10.1097/01.pas.0000176433.81079.bd
  7. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 1986;314:1010-1015. https://doi.org/10.1056/NEJM198604173141603
  8. Kang MJ, Kang H, Kim HO, Park YM. A case of malignant peripheral sheath tumor arising from neurofibromatosis type 1. Ann Dermatol 2008;20:32-36. https://doi.org/10.5021/ad.2008.20.1.32
  9. Gu B, Park JW, Jang LC, Kim SH, Bae IH, Park WY, et al. Retroperitoneal malignant peripheral nerve sheath tumors complicated with type I neurofibromatosis. J Korean Surg Soc 2006;71:365-370.
  10. Kim DH, Lee SS, Lee SH, Lee DW. A case of malignant peripheral nerve sheath tumor of the neck associated with neurofibromatosis type I. Korean J Otorhinolaryngol-Head Neck Surg 2010;53:657-660. https://doi.org/10.3342/kjorl-hns.2010.53.10.657
  11. Kang DY, Park CK, Choi JS, Jin SY, Kim HJ, Joo M, et al. Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients. Am J Surg Pathol 2007;31:224-232. https://doi.org/10.1097/01.pas.0000213318.66800.94
  12. Namgung H. Gastrointestinal stromal tumor with KIT mutation in neurofibromatosis type 1. J Korean Surg Soc 2011;81:276-280. https://doi.org/10.4174/jkss.2011.81.4.276
  13. Seo SO, Oh HJ, Kim KH, Choi CS, Seo GS, Kim TH, et al. A case of duodenal GIST accompanied with neurofibromatosis- 1, presenting with gastrointestinal bleeding. Korean J Gastrointest Endosc 2007;35:254-257.
  14. Myong NH, Lee SS, Shu YL, Chi JG. Optic nerve glioma with neurofibromatosis. Korean J Pathol 1993;27:524-530.
  15. Yi HS, Kim SH, Kim J, Bae EJ, Hong S, Park IB, et al. Mutational analysis of the NF1 gene in two families with neurofibromatosis 1 accompanied by pheochromocytoma. Endocrinol Metab 2011;26:177-184. https://doi.org/10.3803/EnM.2011.26.2.177
  16. Jeong CY, Hong SC, Lee YJ, Jung EJ, Choi SK, Joo YT, et al. Multiple duodeno-jejunal GIST associated with pheochromocytoma in patients with von Recklinghausen disease. J Korean Surg Soc 2005;69:74-78.
  17. Kim KJ, Choi SR, Sohn SH, Lee S, Hong KB, Keum DJ, et al. A case of colon cancer in a patient with neurofibromatosis type I. Korean J Gastroenterol 2002;40:402-405.
  18. Lee MH, Yang JH, Han SD, Kim HR, Jung YK, Kim SM, et al. Apical lung cancer associated with neurofibromatosis type 1. J Korean Neurol Assoc 2004;22:562-563.
  19. Kim SH, Son WJ, Sin DJ, Chang MC. Bilateral metachronous breast cancer in neurofibromatosis type 1. J Korean Surg Soc 2009;76:388-391. https://doi.org/10.4174/jkss.2009.76.6.388
  20. Im DH, Whang HC, Oh JS, Kim HJ, Lee HM, An JK, et al. A case of early gastric adenocarcinoma and intraabdominal schwannoma in a patient with neurofibromatosis type I. Korean J Gastrointest Endosc 2007;34:83-87.

Cited by

  1. A Long-Term Survival Case of a Primary Malignant Intracerebral Nerve Sheath Tumor vol.54, pp.3, 2012, https://doi.org/10.3340/jkns.2013.54.3.261
  2. A genetic model for gallbladder carcinogenesis and its dissemination vol.25, pp.6, 2014, https://doi.org/10.1093/annonc/mdu006
  3. Intestinal obstruction in von Recklinghausen's disease vol.16, pp.10, 2014, https://doi.org/10.1111/codi.12649
  4. Massive Upper Gastrointestinal Bleeding from Multiple Gastrointestinal Stromal Tumor in a Neurofibromatosis Patient vol.64, pp.5, 2014, https://doi.org/10.4166/kjg.2014.64.5.307
  5. Synchronous neuroendocrine tumor and non‐small‐cell lung cancer in neurofibromatosis type 1 vol.3, pp.12, 2015, https://doi.org/10.1002/ccr3.416
  6. Rectal carcinoma and multiple gastrointestinal stromal tumors (GIST) of the small intestine in a patient with neurofibromatosis type 1: a case report vol.15, pp.None, 2012, https://doi.org/10.1186/s12957-017-1231-3
  7. Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature vol.17, pp.None, 2019, https://doi.org/10.1186/s13053-019-0110-z
  8. Benign spindle cell tumor surrounding the bronchovascular structures in a 14‐year‐old male with neurofibromatosis type I vol.55, pp.6, 2012, https://doi.org/10.1002/ppul.24769
  9. Clinical Characteristics, Treatments, and Concurrent Mutations in Non–Small Cell Lung Cancer Patients With NF1 Mutations vol.22, pp.1, 2012, https://doi.org/10.1016/j.cllc.2020.09.011